Compensatory caspase activation in MPP+-induced cell death in dopaminergic neurons

Cellular and Molecular Life Sciences

Volumn 62, Issue 2, 2005, Pages 227-238

  Chee, J L Y ^a   Guan, X L ^a   Lee, J Y ^a   Dong, B ^a   Leong, S M ^a   Ong, E H ^a   Liou, A K F ^b   Lim, T M ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

AIF; Apoptosis; Caspase; Cytochrome c; Dopaminergic neuron; Neurotoxin; Parkinson's disease

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; CASPASE; CASPASE 2; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; ENZYME INHIBITOR; NEUROTOXIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL LINE; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; ENZYME INHIBITION; MESENCEPHALON; MITOCHONDRION; MOUSE; NONHUMAN; SERUM;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; APOPTOSIS; APOPTOSIS INDUCING FACTOR; CASPASE 2; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; CASPASES; CELL LINE; CYTOCHROMES C; DOPAMINE; ENZYME ACTIVATION; FLAVOPROTEINS; MEMBRANE PROTEINS; MICE; MITOCHONDRIA; NEURONS;

ANIMALIA;

EID: 13244255549     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-004-4413-4     Document Type: Article

References (66)

1. Dauer W. and Przedborski S. (2003) Parkinsons disease: mechanisms and models. Neuron 39: 889-909
2. Dawson T. M. and Dawson V. L. (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302: 819-822
3. Lim K. L. and Lim T. M. (2003) Molecular mechanisms of neurodegeneration in Parkinson's disease: clues from Mendelian syndromes. IUBMB Life 55: 315-322
4. Hartmann A., Hunot S., Michel P. P., Muriel M. P., Vyas S., Faucheux B. A. et al. (2000) Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc. Natl. Acad. Sci. USA 97: 2875-2880
5. Blum D., Torch S., Lambeng N., Nissou M., Benabid A. L., Sadoul R. et al. (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 65: 135-172
6. Barzilai A. and Melamed E. (2003) Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease. Trends Mol. Med. 9: 126-132
7. Fiskum G., Starkov A., Polster B. M. and Chinopoulos C. (2003) Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease. Ann. N. Y. Acad. Sci. 991: 111-119
8. Liou A. K., Clark R. S., Henshall D. C., Yin X. M. and Chen J. (2003) To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways. Prog. Neurobiol. 69: 103-142
9. Tatton W. G., Chalmers-Redman R., Brown D. and Tatton N. (2003) Apoptosis in Parkinson's disease: signals for neuronal degradation. Ann Neurol 53 (suppl 3): S61-70; discussion S70-72
10. Mochizuki H., Goto K., Mori H. and Mizuno Y. (1996) Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci. 137: 120-123
11. Kingsbury A. L., Mardsen C. D. and Foster O. J. (1998) DNA fragmentation in human substantia nigra: apoptosis or perimortem effect? Mov. Disord. 13: 877-884
12. Han B. S., Hong H. S., Choi W. S., Markelonis G. J., Oh T. H. and Oh Y. J. (2003) Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment. J. Neurosci. 23: 5069-5078
13. Viswanath V., Wu Z., Fonck C., Wei Q., Boonplueang R. and Andersen J. K. (2000) Transgenic mice neuronally expressing baculoviral p35 are resistant to diverse types of induced apoptosis, including seizure-associated neurodegeneration. Proc. Natl. Acad. Sci. USA 97: 2270-2275
14. Viswanath V., Wu Y., Boonplueang R., Chen S., Stevenson F. F., Yantiri F. et al. (2001) Caspase-9 activation results in down-stream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1.2,3.6-tetrahydropyridine-induced Parkinson's disease. J. Neurosci. 21: 9519-9528
15. Green D. R. and Reed J. C. (1998) Mitochondria and apoptosis. Science 281: 1309-1312
16. Li P., Nijhawan D., Budihardjo I., Srinivasula S. M., Ahmad M., Alnemri E. S. et al. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic pro tease cascade. Cell 91: 479-489
17. Friberg H. and Wieloch T. (2002) Mitochondrial permeability transition in acute neurodegeneration. Biochimie 84: 241-250
18. Fulda S., Susin S. A., Kroemer G. and Debatin K. M. (1998) Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells. Cancer Res. 58: 4453-4460
19. Susin S. A., Lorenzo H. K., Zamzami N., Marzo I., Snow B. E., Brothers G. M. et al. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397: 441-446
20. Fiskum G. (2000) Mitochondrial participation in ischemic and traumatic neural cell death. J. Neurotrauma 17: 843-855
21. Cowling V. and Downward J. (2002) Caspase-6 is the direct activator of caspase-8 in the cytochrome c-induced apoptosis pathway: absolute requirement for removal of caspase-6 prodomain. Cell Death Differ. 9: 1046-1056
22. Zheng T. S., Hunot S., Kuida K., Momoi T., Srinivasan A., Nicholson D. W. et al. (2000) Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation. Nat. Med. 6: 1241-1247
23. Choi W. S., Eom D. S., Han B. S., Kim W. K., Han B. H., Choi E. J. et al. (2004) Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8-and -9-mediated apoptotic pathways in dopaminergic neurons. J. Biol. Chem. 279: 20451-20460
24. Holtz W. A. and O'Malley K. L. (2003) Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J. Biol. Chem. 278: 19367-19377
25. Choi H. K., Won L. A., Kontur P. J., Hammond D. N., Fox A. P., Wainer B. H. et al. (1991) Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Res 552:67-76
26. Choi H. K., Won L., Roback J. D., Wainer B. H. and Heller A. (1992) Specific modulation of dopamine expression in neuronal hybrid cells by primary cells from different brain regions. Proc. Natl. Acad. Sci. USA 89: 8943-8947
27. Davis G. C., Williams A. C., Markey S. P., Ebert M. H., Caine E. D., Reichert C. M. et al. (1979) Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res. 1: 249-254
28. Zhang W. D., Wen Y., Liu S. M., Tjiu W. C., Xu G. Q. and Gan L. M. (2002) Synthesis of vertically aligned carbon nanotubes on metal deposited quartz plates. Carbon 40: 1981-1989
29. Smedes F., Kraak J. C. and Poppe H. (1982) Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline and dopamine from plasma and urine. J. Chromatogr. 231: 25-39
30. Tang L., Todd R. D. and O'Malley K. L. (1994) Dopamine D2 and D3 receptors inhibit dopamine release. J. Pharmacol. Exp. Ther. 270: 475-479
31. +-induced dopaminergic neuronal cell death: role of caspases. ROS, and JNK. J. Neurosci. Res 57: 86-94
32. Choi W. S., Canzoniero L. M., Sensi S. L., O'Malley K. L., Gwag B. J., Sohn S. et al. (1999) Characterization of MPP(+)-induced cell death in a dopaminergic neuronal cell line: role of macromolecule synthesis, cytosolic calcium, caspase, and Bcl-2-related proteins. Exp. Neurol. 159: 274-282
33. Oh J. H., O'Malley K. L., Krajewski S., Reed J. C. and Oh Y. J. (1997) Bax accelerates staurosporine-induced but suppresses nigericin-induced neuronal cell death. Neuroreport 8: 1851-1856
34. Oh Y. J., Uhland-Smith A., Kim J. E. and O'Malley K. L. (1997) Regions outside of the Bcl-2 homology domains, BH1 and BH2 protect a dopaminergic neuronal cell line from staurosporine-induced cell death. Brain Res. Mol. Brain Res. 51: 133-142
35. Oh J. H., Choi W. S., Kim J. E., Seo J. W., O'Malley K. L. and Oh Y. J. (1998) Overexpression of HA-Bax but not Bcl-2 or Bcl-XL attenuates 6-hydroxydopamine-induced neuronal apoptosis. Exp. Neurol. 154: 193-198
36. Perez R. G., Waymire J. C., Lin E., Liu J. J., Guo F. and Zigmond M. J. (2002) A role for alpha-synuclein in the regulation of dopamine biosynthesis. J. Neurosci. 22: 3090-3099
37. Nicklas W. J., Vyas I. and Heikkila R. E. (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1.2,5,6-tetrahydropyridine. Life Sci. 36: 2503-2508
38. +) against mitochondria of mouse brain. J. Neurol. Sci. 86: 97-110
39. Cassarino D. S., Parks J. K., Parker W. D., Jr. and Bennett J. P., Jr. (1999) The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim Biophys. Acta 1453: 49-62
40. Srinivasula S. M., Hegde R., Saleh A., Datta P., Shiozaki E., Chai J. et al. (2001) A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 410: 112-116
41. Deveraux Q. L. and Reed J. C. (1999) IAP family proteins - suppressors of apoptosis. Genes Dev. 13: 239-252
42. Xiao C. W., Ash K. and Tsang B. K. (2001) Nuclear factor-kappaB-mediated X-linked inhibitor of apoptosis protein expression prevents rat granulosa cells from tumor necrosis factor alpha-induced apoptosis. Endocrinology 142: 557-563
43. Wang H., Shimoji M., Yu S. W., Dawson T. M. and Dawson V. L. (2003) Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson's disease. Ann. N. Y. Acad. Sci. 991: 132-139
44. Brunet A., Bonni A., Zigmond M. J., Lin M. Z., Juo P., Hu L. S. et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868
45. Sun C., Cai M., Meadows R. P., Xu N., Gunasekera A. H., Herrmann J. et al. (2000) NMR structure and mutagenesis of the third Bir domain of the inhibitor of apoptosis protein XIAP. J. Biol. Chem. 275: 33777-33781
46. Zhang Y., Dawson V. L. and Dawson T. M. (2000) Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol. Dis. 7: 240-250
47. Kagawa S., Gu J., Honda T., McDonnell T. J., Swisher S. G., Roth J. A. et al. (2001) Deficiency of caspase-3 in MCF7 cells blocks Bax-mediated nuclear fragmentation but not cell death. Clin. Cancer Res. 7: 1474-1480
48. Lassus P., Opitz-Araya X. and Lazebnik Y. (2002) Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297: 1352-1354
49. Guo Y., Srinivasula S. M., Druilhe A., Fernandes-Alnemri T. and Alnemri E. S. (2002) Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J. Biol. Chem. 277: 13430-13437
50. Degterev A., Boyce M. and Yuan J. (2003) A decade of caspases. Oncogene 22: 8543-8567
51. Hirata H., Takahashi A., Kobayashi S., Yonehara S., Sawai H., Okazaki T. et al. (1998) Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J. Exp. Med. 187: 587-000
52. Talanian R. V., Quinlan C., Trautz S., Hackett M. C., Mankovich J. A., Banach D. et al. (1997) Substrate specificities of caspase family proteases. J. Biol. Chem. 272: 9677-9682
53. Thornberry N. A., Rano T. A., Peterson E. P., Rasper D. M., Timkey T., Garcia-Calvo M. et al. (1997) A combinatorial approach defines specificities of members of the caspase family and granzyme B: functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272: 17907-17911
54. Nakagawa T. and Yuan J. (2000) Cross-talk between two cysteine protease families: activation of caspase-12 by calpain in apoptosis. J. Cell. Biol. 150: 859-854
55. Rao R. V., Hermel E., Castro-Obregon S., Rio G. del Ellerby L. M., Ellerby H. M. et al. (2001) Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J. Biol. Chem. 276: 33869-33874
56. Morishima N., Nakanishi K., Takenouchi H., Shibata T. and Yasuhiko Y. (2002) An endoplasmic reticulum stress-specific caspase cascade in apoptosis: cytochrome c-independent activation of caspase-9 by caspase-12. J. Biol. Chem. 277: 34287-34294
57. Rao R. V., Castro-Obregon S., Frankowski H., Schuler M., Stoka V., del Rio G. et al. (2002) Coupling endoplasmic reticulum stress to the cell death program: an Apaf-1-independent intrinsic pathway. J. Biol. Chem. 277: 21836-21842
58. Boehning D, Patterson R. L., Sedaghat L., Glebova N. O., Kurosaki T. and Snyder S. H. (2003) Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis. Nat. Cell. Biol. 5: 1051-1061
59. Hitomi J., Katayama T., Taniguchi M., Honda A., Imaizumi K., and Tohyama M. (2003) Apoptosis induced by endoplasmic reticulum stress depends on activation of caspase-3 via caspase-12. Neurosci. Lett. 357: 127-130
60. Momoi T. (2004) Caspases involved in ER stress-mediated cell death. J. Chem. Neuro. 28: 101-105
61. Daugas E., Susin S. A., Zamzami N., Ferri K. F., Irinopoulou T., Larochette N. et al. (2000) Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J. 14: 729-739
62. Kuwana T., Smith J. J., Muzio M., Dixit V., Newmeyer D. D. and Kornbluth S. (1998) Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J. Biol. Chem. 273: 16589-16594
63. Srinivasula S. M., Ahmad M., Fernandes-Alnemri T. and Alnemri E. S. (1998) Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell. 1: 949-957
64. Li H., Zhu H., Xu C. J. and Yuan J. (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501
65. Luo X., Budihardjo I., Zou H., Slaughter C. and Wang X. (1998) Bid, a Bcl2 interacting protein, mediates cytochroine c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-490
66. Hartmann A., Troadec J. D., Hunot S., Kikly K., Faucheux B. A., Mouatt-Prigent A. et al. (2001) Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis. J. Neurosci. 21: 2247-2255